ITGAL and carcinoma: We found that specifically blocking CD11a, CD11b or CD18 on M2a macrophages or ICAM-1 on A549 aggregates significantly inhibited carcinoma aggregate dissociation, whereas blocking CD11c had no effect (Figure 5B).